AmeriCann, Inc. Stock price

Equities

ACAN

US0305881072

Healthcare Facilities & Services

Delayed OTC Markets 10:53:43 2024-03-27 am EDT 5-day change 1st Jan Change
0.06 USD 0.00% Intraday chart for AmeriCann, Inc. +8.89% -29.41%
Sales 2022 2.93 Sales 2023 2.55 Capitalization 8.05M
Net income 2022 - Net income 2023 - EV / Sales 2022 5,058,436 x
Net Debt 2022 7.96M Net Debt 2023 8.16M EV / Sales 2023 6,352,394 x
P/E ratio 2022
-28.1 x
P/E ratio 2023
-85 x
Employees 3
Yield 2022 *
-
Yield 2023
-
Free-Float 56.32%
More Fundamentals * Assessed data
Dynamic Chart
1 week+8.89%
Current month-1.64%
1 month-5.96%
3 months-15.49%
6 months-80.33%
Current year-29.41%
More quotes
1 week
0.06
Extreme 0.0551
0.07
1 month
0.05
Extreme 0.0522
0.10
Current year
0.05
Extreme 0.0522
0.14
1 year
0.05
Extreme 0.051
0.42
3 years
0.05
Extreme 0.051
1.62
5 years
0.05
Extreme 0.051
1.99
10 years
0.05
Extreme 0.051
6.00
More quotes
Managers TitleAgeSince
Founder 60 10-06-24
Chief Executive Officer 45 14-03-24
Members of the board TitleAgeSince
Chief Executive Officer 45 14-03-24
Founder 60 10-06-24
Director/Board Member 36 19-01-29
More insiders
Date Price Change Volume
24-03-27 0.06 0.00% 2,070
24-03-26 0.06 +8.89% 2,665
24-03-25 0.0551 -8.17% 2,846
24-03-21 0.06 +8.89% 2,550
24-03-20 0.0551 -4.26% 19,823

Delayed Quote OTC Markets, March 27, 2024 at 10:53 am EDT

More quotes
AmeriCann, Inc. is a cannabis company that develops cultivation, processing and product manufacturing facilities. It has provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals and concentrates. It designs GMP-certified cannabis extraction and product manufacturing infrastructure. Its flagship project is the Massachusetts Cannabis Center (MCC), which is being developed on a 52-acre parcel. MCC project is permitted for over 800,000 square feet of cannabis cultivation and processing infrastructure which is being developed in phases to support both the existing medical cannabis and the emerging adult-use cannabis marketplace. The Company, through a 100% owned subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated market.
More about the company
  1. Stock
  2. Equities
  3. Stock AmeriCann, Inc. - OTC Markets